Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pittrow

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
European Heart Journal|June 20, 2006
Association of low ankle brachial index with high mortality in primary careCurt Diehm, Stefan Lange, Harald Darius, et al.
The Journal of Clinical Endocrinology and Metabolism|November 16, 2006
Accuracy of anthropometric indicators of obesity to predict cardiovascular riskHarald J Schneider, Heide Glaesmer, Jens Klotsche, et al.
The Journal of Rheumatology|May 5, 2007
Systemic sclerosis - continuing progress in developing clinical measures of responseDaniel Furst, Dinesh Khanna, Marco Matucci-Cerinic, et al.
Orphanet Journal of Rare Diseases|June 12, 2023
Detect Acute Porphyrias in Emergency Departments (DePorED) - a pilot studyEva Diehl-Wiesenecker, Sabine Blaschke, Nils Wohmann, et al.
Acta Cardiologica|April 24, 2025
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS studyKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
International Journal of Methods in Psychiatric Research|August 16, 2005
Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA studyHans-Ulrich Wittchen, Sabine M Apelt, Gerhard Bühringer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 4, 2025
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodiesKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Journal of Hypertension|April 13, 2004
High prevalence and poor control of hypertension in primary care: cross-sectional studyArya M Sharma, Hans-Ulrich Wittchen, Wilhelm Kirch, et al.
Plos One|January 4, 2013
Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patientsAlexander Michael Labeit, Jens Klotsche, Lars Pieper, et al.
Cardiovascular Diagnosis and Therapy|May 19, 2025
Establishing a cardiology registry: navigating quality and regulatory challenges with a focus on congenital heart diseaseRobert David Pittrow, Oliver Dewald, Frank Harig, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
European Heart Journal|June 20, 2006
Association of low ankle brachial index with high mortality in primary careCurt Diehm, Stefan Lange, Harald Darius, et al.
The Journal of Clinical Endocrinology and Metabolism|November 16, 2006
Accuracy of anthropometric indicators of obesity to predict cardiovascular riskHarald J Schneider, Heide Glaesmer, Jens Klotsche, et al.
The Journal of Rheumatology|May 5, 2007
Systemic sclerosis - continuing progress in developing clinical measures of responseDaniel Furst, Dinesh Khanna, Marco Matucci-Cerinic, et al.
Orphanet Journal of Rare Diseases|June 12, 2023
Detect Acute Porphyrias in Emergency Departments (DePorED) - a pilot studyEva Diehl-Wiesenecker, Sabine Blaschke, Nils Wohmann, et al.
Acta Cardiologica|April 24, 2025
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS studyKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
International Journal of Methods in Psychiatric Research|August 16, 2005
Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA studyHans-Ulrich Wittchen, Sabine M Apelt, Gerhard Bühringer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 4, 2025
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodiesKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Journal of Hypertension|April 13, 2004
High prevalence and poor control of hypertension in primary care: cross-sectional studyArya M Sharma, Hans-Ulrich Wittchen, Wilhelm Kirch, et al.
Plos One|January 4, 2013
Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patientsAlexander Michael Labeit, Jens Klotsche, Lars Pieper, et al.
Cardiovascular Diagnosis and Therapy|May 19, 2025
Establishing a cardiology registry: navigating quality and regulatory challenges with a focus on congenital heart diseaseRobert David Pittrow, Oliver Dewald, Frank Harig, et al.
Pageof 15